跳至主要内容
临床试验/CTRI/2026/02/102791
CTRI/2026/02/102791尚未招募2 期

Studying Effectiveness of Individualised Homoeopathic medicine versus calcaria Phosphorica 6x in the management of Osteoporosis among postmenopaual women - A Comparative study

Dr Bhagyashri Babanrao Wankhede1 个研究点 分布在 1 个国家目标入组 146 人开始时间: 2026年2月16日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
146
试验地点
1
主要终点
To determine effectiveness of Individualised Homoeopathic Medicine with compare to Calcaria Phosphorica 6x in the management of Osteoporosis among post menopausal women

研究概览

简要总结

This study aims to compare the effectiveness of Individualised Homoeopathic medicines with Calcarea Phosphorica 6X in the management of osteoporosis among post menopausal women.

Background: Osteoporosis is a widespread condition leading to reduced bone density and fragility fractures, with high prevalence in Indian post menopausal women. Conventional treatments (bisphosphonates, calcium, vitamin D) have side effects and limitations, prompting the need for safer, cost effective alternatives.

Rationale: Homoeopathy with its holistic and individualised  approach, may offer effective management. Calcarea Phosphorica a biochemic tissue salt  is traditionally linked to bone health. Few comparative studies exist, highlighting a knowledge gap.

Aim: To assess whether individualised homoeopathic medicines are more effective than Calcarea Phosphorica 6X in

improving bone mineral density (BMD) and clinical symptoms of osteoporosis.

Methodology:  Design: Single-blind, randomized comparative                                               clinical trial.

Population: 146 post menopausal women with osteoporosis (BMD T-score < -2.5).

Group A – Individualised homoeopathic medicines.

Group B – Calcarea Phosphorica 6X (fixed dose).

Duration: 3 years, with periodic follow-ups.

Outcomes: Changes in BMD (DEXA scans)

pain (VAS scale) and

common osteoporosis symptoms.

Expected Contribution: This study will provide evidence on comparative efficacy, possibly positioning Calcarea Phosphorica 6X as a substitute for calcium supplements and

enriching literature on homeopathic management of Osteoporosis.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
45.00 Year(s) 至 75.00 Year(s)(—)
性别
Female

入选标准

  • Posenopausal women having their BMD T score less than or equal to -2.5 will be included in the study.

排除标准

  • Patient having associated endocrinal disorder like Adrenal insufficiency,Cushing Syndrome,Central adiposity ,Diabetes mellitus Type1 and 2,Hyperparathyroidism,Thyrotoxicosis.

结局指标

主要结局

To determine effectiveness of Individualised Homoeopathic Medicine with compare to Calcaria Phosphorica 6x in the management of Osteoporosis among post menopausal women

时间窗: 1year

次要结局

  • To determine effectiveness of Individualised Homoeopathic Medicine with compare to Calcaria Phosphorica 6x in improving BMD Tscore among postmenopaual women(1year)

研究者

发起方
Dr Bhagyashri Babanrao Wankhede
申办方类型
Other [Self ]
责任方
Principal Investigator
主要研究者

Dr Bhagyashri Babanrao Wankhede

Dhondhumama sathe Homoeopathic Medical College and NMRM Hospital Pune

研究点 (1)

Loading locations...

相似试验